Editor03.02.10
Gambro has purchased CHF Solutions Inc., a medical device company that manufactures and distributes ultrafiltration devices to treat fluid overload, for an undisclosed amount, according to both firms.
CHF's main product is the Aquadex FlexFlow system, a mechanical pump and filter to treat fluid overload. Gambro is a developer, manufacturer and supplier of devices, therapies and services for self-care hemodialysis, peritoneal dialysis, renal intensive care and hepatic care.
“This acquisition will enable Gambro to accelerate the adoption of ultrafiltration for fluid overload, thereby expanding our product offerings and providing a broader spectrum of care to patients. CHF brings a proven therapy, superior clinical results and established relationships with physicians," said Nick Mendez, president of the Gambro Acute Business Unit.
CHF's main product is the Aquadex FlexFlow system, a mechanical pump and filter to treat fluid overload. Gambro is a developer, manufacturer and supplier of devices, therapies and services for self-care hemodialysis, peritoneal dialysis, renal intensive care and hepatic care.
“This acquisition will enable Gambro to accelerate the adoption of ultrafiltration for fluid overload, thereby expanding our product offerings and providing a broader spectrum of care to patients. CHF brings a proven therapy, superior clinical results and established relationships with physicians," said Nick Mendez, president of the Gambro Acute Business Unit.
Ultrafiltration is a treatment in which water, salt and other blood constituents are removed by a filter.